Dexcom | DXCM - 销售和管理费用

金融业

USD

USD 6.63B

现金及等价物

USD 1.12B

USD 441.6M

USD 4.33B

USD 2.22B

USD 1.24B

USD 255.3M

USD 364.5M

10.3K

EPS每股收益

USD 0.56

股本和储备

USD 2.96B

USD 750.3M

债务利息支出

USD 4.2M

USD 23.5M

USD 1.3B

USD 28.22B

USD 199.5M

USD 936.6M

USD 255.3M

普通股股本

USD 385.9M

24.73

USD 340.7M

USD 1.19B

销售和管理费用

USD 349.7M

USD 693.6M

贸易债权人

USD 1.94B

应收帐款人

USD 1.09B

	销售和管理费用	更改		日
Abbott	USD 3.27B		138M	2026-03
Align Technology	USD 465.34M		23.67M	2026-03
AtriCure	USD 84.55M		6.21M	2026-03
Avanos Medical	USD 77.7M		1.1M	2026-03
Baxter International	USD 728M		33M	2026-03
Becton, Dickinson and Co.	USD 1.21B		180M	2026-03
Boston Scientific	USD 1.78B		53M	2026-03
Cooper Companies	USD 373.1M		46.1M	2025-12
Dexcom	USD 349.7M		49.8M	2026-03
Edwards Lifesciences	USD 522.2M		80.7M	2026-03
Globus Medical	USD 297.77M		20.7M	2026-03
Inogen	USD 43.77M		510K	2024-06
Insulet	USD 317.2M		14.2M	2026-03
Integra LifeSciences	USD 178.24M		21.79M	2026-03
J&J	USD 6.03B		719M	2026-03
Masimo	USD 143.4M		15.4M	2026-03
Medtronic	2.97B		159M	2025-09
Merit Medical Systems	USD 110.47M		4.36M	2026-03
Roche Holding	CHF 7.28B		3.99B	2025-12
Solventum Corp	USD 783M		24M	2026-03
Stryker	USD 2.15B		17M	2026-03
Tandem Diabetes Care	USD 99.86M		5.34M	2025-12
Teleflex	USD 226.01M		3.64M	2026-03
West Pharmaceutical Services	USD 99.5M		7M	2026-03
Zimmer Biomet Holdings	USD 849.9M		5.8M	2026-03